These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15379603)

  • 21. Morphinan neuroprotection: new insight into the therapy of neurodegeneration.
    Zhang W; Hong JS; Kim HC; Zhang W; Block ML
    Crit Rev Neurobiol; 2004; 16(4):271-302. PubMed ID: 15862109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators?
    Ensoli F; Fiorelli V; Muratori DS; De Cristofaro M; Vincenzi L; Topino S; Novi A; Luzi G; Sirianni MC
    Crit Rev Immunol; 1999; 19(2):97-116. PubMed ID: 10352899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of neuroinflammation: Role and therapeutic potential of TRPV1 in the neuro-immune axis.
    Kong WL; Peng YY; Peng BW
    Brain Behav Immun; 2017 Aug; 64():354-366. PubMed ID: 28342781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglia in central nervous system repair after injury.
    Jin X; Yamashita T
    J Biochem; 2016 May; 159(5):491-6. PubMed ID: 26861995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Osteopontin on Microglia.
    Yu H; Liu X; Zhong Y
    Biomed Res Int; 2017; 2017():1879437. PubMed ID: 28698867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
    Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
    J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications.
    Magnus T; Chan A; Savill J; Toyka KV; Gold R
    J Neuroimmunol; 2002 Sep; 130(1-2):1-9. PubMed ID: 12225883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylethanolamide in CNS health and disease.
    Mattace Raso G; Russo R; Calignano A; Meli R
    Pharmacol Res; 2014 Aug; 86():32-41. PubMed ID: 24844438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway.
    Pais TF; Figueiredo C; Peixoto R; Braz MH; Chatterjee S
    J Neuroinflammation; 2008 Oct; 5():43. PubMed ID: 18844999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders.
    Drew PD; Xu J; Storer PD; Chavis JA; Racke MK
    Neurochem Int; 2006 Jul; 49(2):183-9. PubMed ID: 16753239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids.
    Suk K
    Neurosignals; 2005; 14(1-2):23-33. PubMed ID: 15956812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomaterials and glia: Progress on designs to modulate neuroinflammation.
    Tsui C; Koss K; Churchward MA; Todd KG
    Acta Biomater; 2019 Jan; 83():13-28. PubMed ID: 30414483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARgamma as a therapeutic target in central nervous system diseases.
    Sundararajan S; Jiang Q; Heneka M; Landreth G
    Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia Function in the Central Nervous System During Health and Neurodegeneration.
    Colonna M; Butovsky O
    Annu Rev Immunol; 2017 Apr; 35():441-468. PubMed ID: 28226226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation.
    Fabriek BO; Van Haastert ES; Galea I; Polfliet MM; Döpp ED; Van Den Heuvel MM; Van Den Berg TK; De Groot CJ; Van Der Valk P; Dijkstra CD
    Glia; 2005 Sep; 51(4):297-305. PubMed ID: 15846794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
    Marchetti B; Abbracchio MP
    Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic regulation of brain inflammatory responses.
    Galea E; Heneka MT; Dello Russo C; Feinstein DL
    Cell Mol Neurobiol; 2003 Oct; 23(4-5):625-35. PubMed ID: 14514020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflamm-aging and neurodegenerative diseases: an overview.
    Pizza V; Agresta A; D'Acunto CW; Festa M; Capasso A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):621-34. PubMed ID: 21631404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer.
    Sevenich L
    Front Immunol; 2018; 9():697. PubMed ID: 29681904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.